Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 328 articles: HTML format

Single Articles

September 2022
1. HECHT S, Butcher SC, Pio SM, Kong WKF, et al
   Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease.
   J Am Coll Cardiol. 2022;80:1071-1084.
   PubMed     Abstract available
   
   
   
2. SENGUPTA A, Beroukhim R, Baird CW, Del Nido PJ, et al
   Outcomes of Repair of Congenital Aortic Valve Lesions Using Autologous Pericardium vs Porcine Intestinal Submucosa.
   J Am Coll Cardiol. 2022;80:1060-1068.
   PubMed     Abstract available
   
   
   
3. CUI H, Schaff HV
   Reply: Long-Term Mortality in Obstructive Hypertrophic Cardiomyopathy: Looking Beyond the Assigned Treatment.
   J Am Coll Cardiol. 2022;80:e89.
   PubMed    
   
   
   
4. MOUKARBEL GV, Cooper CJ
   Long-Term Mortality in Obstructive Hypertrophic Cardiomyopathy: Looking Beyond the Assigned Treatment.
   J Am Coll Cardiol. 2022;80:e87.
   PubMed    
   
   
   
5. KOVACIC JC, Fuster V
   Exercise, Cardiovascular Disease, and the Athlete's Heart.
   J Am Coll Cardiol. 2022;80:1088-1090.
   PubMed    
   
   
   
6. DONAL E, Magne J, Cosyns B
   Left Ventricular Ejection Fraction Thresholds Reappraisal: Also for Bicuspid Valve Disease?
   J Am Coll Cardiol. 2022;80:1085-1087.
   PubMed    
   
   
   
7. MA M
   Are There Still Reasons to Use Porcine Small Intestinal Submucosa?
   J Am Coll Cardiol. 2022;80:1069-1070.
   PubMed    
   
   
   
8. SIMARD T, Vemulapalli S, Jung RG, Vekstein A, et al
   Transcatheter Edge-to-Edge Repair in Patients with Severe Mitral Regurgitation and Cardiogenic Shock: TVT Registry Analysis.
   J Am Coll Cardiol. 2022 Sep 13. pii: S0735-1097(22)06767.
   PubMed     Abstract available
   
   
   
9. SHARMA T, Krishnan AM, Lahoud R, Polomsky M, et al
   National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis.
   J Am Coll Cardiol. 2022 Sep 8. pii: S0735-1097(22)06756.
   PubMed    
   
   
   August 2022
10. PARIKH PB
    Predicting Futility in Aortic Stenosis: What's the Holdup?
    J Am Coll Cardiol. 2022;80:801-803.
    PubMed    
    
    
    
11. CHURCHILL TW, Yucel E, Deferm S, Levine RA, et al
    Mitral Valve Dysfunction in Patients With Annular Calcification: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:739-751.
    PubMed     Abstract available
    
    
    
12. HAYASHIDA K
    Transcatheter Valve Treatment for a Failed Small Surgical Aortic Valve: Addressing the Achilles' Heel.
    J Am Coll Cardiol. 2022;80:694-696.
    PubMed    
    
    
    
13. OH JK, Ito S
    Severity of Aortic Stenosis: A Moving Target.
    J Am Coll Cardiol. 2022;80:677-680.
    PubMed    
    
    
    
14. STASSEN J, Ewe SH, Singh GK, Butcher SC, et al
    Prevalence and Prognostic Implications of Discordant Grading and Flow-Gradient Patterns in Moderate Aortic Stenosis.
    J Am Coll Cardiol. 2022;80:666-676.
    PubMed     Abstract available
    
    
    
15. CHEHAB O, Roberts-Thomson R, Bivona A, Gill H, et al
    Management of Patients With Severe Mitral Annular Calcification: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:722-738.
    PubMed     Abstract available
    
    
    
16. RODES-CABAU J, Abbas AE, Serra V, Vilalta V, et al
    Balloon- vs Self-Expanding Valve Systems for Failed Small Surgical Aortic Valve Bioprostheses.
    J Am Coll Cardiol. 2022;80:681-693.
    PubMed     Abstract available
    
    
    
17. PANDEY A, Adedinsewo D
    The Future of AI-Enhanced ECG Interpretation for Valvular Heart Disease Screening.
    J Am Coll Cardiol. 2022;80:627-630.
    PubMed    
    
    
    
18. ELIAS P, Poterucha TJ, Rajaram V, Moller LM, et al
    Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.
    J Am Coll Cardiol. 2022;80:613-626.
    PubMed     Abstract available
    
    
    
19. PIBAROT P, Herrmann HC, Wu C, Hahn RT, et al
    Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:545-561.
    PubMed     Abstract available
    
    
    
20. HERRMANN HC, Pibarot P, Wu C, Hahn RT, et al
    Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:527-544.
    PubMed     Abstract available
    
    
    
21. BEERI R
    Ischemic Mitral Regurgitation and Leaflet Remodeling: Another Arrow Hits the Target.
    J Am Coll Cardiol. 2022;80:511-512.
    PubMed    
    
    
    
22. MARSIT O, Clavel MA, Paquin A, Deschenes V, et al
    Effects of Cyproheptadine on Mitral Valve Remodeling and Regurgitation After Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:500-510.
    PubMed     Abstract available
    
    
    
23. NEKOUI M, Pirruccello JP, Di Achille P, Choi SH, et al
    Spatially Distinct Genetic Determinants of Aortic Dimensions Influence Risks of Aneurysm and Stenosis.
    J Am Coll Cardiol. 2022;80:486-497.
    PubMed     Abstract available
    
    
    July 2022
24. HARIRI EH, Kassis N, Badwan OZ, Al Hammoud MM, et al
    Impact of Oral Anticoagulation on Progression and Long-Term Outcomes of Mild or Moderate Aortic Stenosis.
    J Am Coll Cardiol. 2022;80:181-183.
    PubMed    
    
    
    
25. DESAI MY, Owens A, Geske JB, Wolski K, et al
    Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.
    J Am Coll Cardiol. 2022;80:95-108.
    PubMed     Abstract available
    
    
    
26. OMMEN SR
    Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: Where Are We on the Hype Cycle?
    J Am Coll Cardiol. 2022;80:109-110.
    PubMed    
    
    
    June 2022
27. DALEN M, Persson M, Glaser N, Sartipy U, et al
    Socioeconomic Status and Risk of Bleeding After Mechanical Aortic Valve Replacement.
    J Am Coll Cardiol. 2022;79:2502-2513.
    PubMed     Abstract available
    
    
    
28. RAPOSEIRAS-ROUBIN S, Abu Assi E, Estevez Loureiro R, Iniguez Romo A, et al
    Reply: Risk Scores for Mortality Prediction After Transcatheter Mitral Valve Repair.
    J Am Coll Cardiol. 2022;79:e479.
    PubMed    
    
    
    
29. SPIEKER M, Zweck E, Pfister R, Ulrich Becher M, et al
    Risk Scores for Mortality Prediction After Transcatheter Mitral Valve Repair.
    J Am Coll Cardiol. 2022;79:e477-e478.
    PubMed    
    
    
    May 2022
30. HOLMES KW, Markwardt S, Eagle KA, Devereux RB, et al
    Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.
    J Am Coll Cardiol. 2022;79:2069-2081.
    PubMed     Abstract available
    
    
    
31. ROSSANO JW, Lin KY
    Hypertrophic Cardiomyopathy: A Problem at Any Age.
    J Am Coll Cardiol. 2022;79:1998-2000.
    PubMed    
    
    
    
32. NORRISH G, Cleary A, Field E, Cervi E, et al
    Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1986-1997.
    PubMed     Abstract available
    
    
    
33. GENEREUX P, Pibarot P, Redfors B, Bax JJ, et al
    Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.
    J Am Coll Cardiol. 2022 May 14. pii: S0735-1097(22)04979.
    PubMed     Abstract available
    
    
    
34. DORFMAN AL, Del Nido PJ
    The Right Ventricle and Tricuspid Valve in Fontan Failure: A Role for Early Surgical Management.
    J Am Coll Cardiol. 2022;79:1846-1848.
    PubMed    
    
    
    
35. SHERRID MV, Massera D, Swistel DG
    Surgical Septal Myectomy and Alcohol Ablation: Not Equivalent in Efficacy or Survival.
    J Am Coll Cardiol. 2022;79:1656-1659.
    PubMed    
    
    
    
36. CUI H, Schaff HV, Wang S, Lahr BD, et al
    Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1647-1655.
    PubMed     Abstract available
    
    
    April 2022
37. BORLAUG BA, Omote K
    Beta-Blockers and Exercise Hemodynamics in Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1576-1578.
    PubMed    
    
    
    
38. DYBRO AM, Rasmussen TB, Nielsen RR, Ladefoged BT, et al
    Effects of Metoprolol on Exercise Hemodynamics in Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1565-1575.
    PubMed     Abstract available
    
    
    
39. LAMPERT J, Pulaski M, Miller MA, Whang W, et al
    Right Precordial U-Waves in Severe Aortic Stenosis: "Real World" Prevalence and Diminution by TAVR.
    J Am Coll Cardiol. 2022 Apr 20. pii: S0735-1097(22)04813.
    PubMed    
    
    
    
40. HAHN RT, Clavel MA, Mascherbauer J, Mick SL, et al
    Sex-Related Factors in Valvular Heart Disease: JACC Focus Seminar 5/7.
    J Am Coll Cardiol. 2022;79:1506-1518.
    PubMed     Abstract available
    
    
    
41. AKODAD M, Blanke P, Chuang MA, Duchscherer J, et al
    Late Balloon Valvuloplasty for Transcatheter Heart Valve Dysfunction.
    J Am Coll Cardiol. 2022;79:1340-1351.
    PubMed     Abstract available
    
    
    
42. SZERLIP M, Mack MJ
    The Management of Transcatheter Heart Valve Dysfunction: Another Tool in the Box.
    J Am Coll Cardiol. 2022;79:1352-1355.
    PubMed    
    
    
    
43. ITCHHAPORIA D
    TAVR 20 Years Later: A Story of Disruptive Transformation.
    J Am Coll Cardiol. 2022;79:1314-1316.
    PubMed    
    
    
    March 2022
44. AMBARDEKAR AV, Stratton MS, Weiser-Evans MCM, Moulton KS, et al
    Reply: Aortic Valve Remodeling in CF-LVAD: Beyond the Arterial Wall.
    J Am Coll Cardiol. 2022;79:e223.
    PubMed    
    
    
    
45. GAZZOLI F, Urtis M, Pagani F, Pelenghi S, et al
    Aortic Valve Remodeling in CF-LVAD: Beyond the Arterial Wall.
    J Am Coll Cardiol. 2022;79:e221-e222.
    PubMed    
    
    
    
46. MAZINE A, David TE, Stoklosa K, Chung J, et al
    Improved Outcomes Following the Ross Procedure Compared With Bioprosthetic Aortic Valve Replacement.
    J Am Coll Cardiol. 2022;79:993-1005.
    PubMed     Abstract available
    
    
    
47. MARWICK TH, Brugger N
    Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation.
    J Am Coll Cardiol. 2022;79:962-964.
    PubMed    
    
    
    
48. SOULAT-DUFOUR L, Lang S, Addetia K, Ederhy S, et al
    Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:951-961.
    PubMed     Abstract available
    
    
    
49. OZKAN M, Gunduz S, Guner A, Kalcik M, et al
    Thrombolysis or Surgery in Patients With Obstructive Mechanical Valve Thrombosis: The Multicenter HATTUSHA Study.
    J Am Coll Cardiol. 2022;79:977-989.
    PubMed     Abstract available
    
    
    
50. TISON GH, Siontis KC, Abreau S, Attia Z, et al
    Assessment of Disease Status and Treatment Response With Artificial Intelligence-Enhanced Electrocardiography in Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1032-1034.
    PubMed    
    
    
    
51. EL-HAMAMSY I, O'Gara PT, Adams DH
    The Ross Procedure: Clinical Relevance, Guidelines Recognition, and Centers of Excellence.
    J Am Coll Cardiol. 2022;79:1006-1009.
    PubMed    
    
    
    
52. FORREST JK, Deeb GM, Yakubov SJ, Rovin JD, et al
    2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
    J Am Coll Cardiol. 2022;79:882-896.
    PubMed     Abstract available
    
    
    
53. LINDMAN BR, Lowenstern A
    The Alarm Blares for Undertreatment of Aortic Stenosis: How Will We Respond?
    J Am Coll Cardiol. 2022;79:878-881.
    PubMed    
    
    
    
54. LI SX, Patel NK, Flannery LD, Selberg A, et al
    Trends in Utilization of Aortic Valve Replacement for Severe Aortic Stenosis.
    J Am Coll Cardiol. 2022;79:864-877.
    PubMed     Abstract available
    
    
    
55. THOURANI VH, Yadav PK, Prendergast B
    TAVR Sustains Its Promise in Low-Risk Patients, But the Journey Is Far From Over.
    J Am Coll Cardiol. 2022;79:897-899.
    PubMed    
    
    
    
56. EL-HAMAMSY I, Toyoda N, Itagaki S, Stelzer P, et al
    Propensity-Matched Comparison of the Ross Procedure and Prosthetic Aortic Valve Replacement in Adults.
    J Am Coll Cardiol. 2022;79:805-815.
    PubMed     Abstract available
    
    
    
57. CHIKWE J
    Evidence Gaps and Endocarditis After Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2022;79:786-788.
    PubMed    
    
    
    
58. MANGNER N, Val DD, Abdel-Wahab M, Crusius L, et al
    Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation.
    J Am Coll Cardiol. 2022;79:772-785.
    PubMed     Abstract available
    
    
    
59. VALLE JA, Fullerton D, Cleveland J, Messenger JC, et al
    Reply: Rational Dispersion of TAVR: The Role of Training Centers.
    J Am Coll Cardiol. 2022;79:e187.
    PubMed    
    
    
    
60. PANT S
    Rational Dispersion of TAVR: The Role of Training Centers.
    J Am Coll Cardiol. 2022;79:e185.
    PubMed    
    
    
    February 2022
61. RAPOSEIRAS-ROUBIN S, Adamo M, Freixa X, Arzamendi D, et al
    A Score to Assess Mortality After Percutaneous Mitral Valve Repair.
    J Am Coll Cardiol. 2022;79:562-573.
    PubMed     Abstract available
    
    
    
62. KALTOFT M, Langsted A, Afzal S, Kamstrup PR, et al
    Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease.
    J Am Coll Cardiol. 2022;79:545-558.
    PubMed     Abstract available
    
    
    
63. ALKHOULI M, Palacios IF, Jneid H
    Risk Stratification of Patients Undergoing Mitral TEER.
    J Am Coll Cardiol. 2022;79:574-576.
    PubMed    
    
    
    
64. RUDSKI LG, Afilalo J
    Right Ventricle-Pulmonary Artery Coupling in Percutaneous Tricuspid Valve Repair: Is Simple Sufficient?
    J Am Coll Cardiol. 2022;79:462-464.
    PubMed    
    
    
    
65. BRENER MI, Lurz P, Hausleiter J, Rodes-Cabau J, et al
    Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair.
    J Am Coll Cardiol. 2022;79:448-461.
    PubMed     Abstract available
    
    
    
66. MARON BJ, Desai MY, Nishimura RA, Spirito P, et al
    Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:390-414.
    PubMed     Abstract available
    
    
    
67. MARON BJ, Desai MY, Nishimura RA, Spirito P, et al
    Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:372-389.
    PubMed     Abstract available
    
    
    January 2022
68. MACK MJ, Leon MB, Wu C, Zuckerman B, et al
    The Heart Valve Collaboratory: A Disruptive Model in the Management of Valvular Heart Disease.
    J Am Coll Cardiol. 2022;79:192-196.
    PubMed    
    
    
    
69. MENTIAS A, Keshvani N, Desai MY, Kumbhani DJ, et al
    Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance Metric.
    J Am Coll Cardiol. 2022;79:132-144.
    PubMed     Abstract available
    
    
    
70. SHERWOOD MW, Vora AN
    For TAVR, Home Is Where the Heart Is.
    J Am Coll Cardiol. 2022;79:145-147.
    PubMed    
    
    
    December 2021
71. URETSKY S, Morales DCV, Aldaia L, Mediratta A, et al
    Characterization of Primary Mitral Regurgitation With Flail Leaflet and/or Wall-Impinging Flow.
    J Am Coll Cardiol. 2021;78:2537-2546.
    PubMed     Abstract available
    
    
    
72. SHAH DJ, El-Tallawi KC
    Not All Flails Are Created Equal.
    J Am Coll Cardiol. 2021;78:2547-2549.
    PubMed    
    
    
    
73. MASRI A
    A New Dawn in HCM: Rise of the RCTs.
    J Am Coll Cardiol. 2021;78:2533-2536.
    PubMed    
    
    
    
74. HEGDE SM, Lester SJ, Solomon SD, Michels M, et al
    Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:2518-2532.
    PubMed     Abstract available
    
    
    
75. DYBRO AM, Rasmussen TB, Nielsen RR, Andersen MJ, et al
    Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:2505-2517.
    PubMed     Abstract available
    
    
    
76. NTUSI NAB, Sliwa K
    Associations of Race and Ethnicity With Presentation and Outcomes of Hypertrophic Cardiomyopathy: JACC Focus Seminar 6/9.
    J Am Coll Cardiol. 2021;78:2573-2579.
    PubMed     Abstract available
    
    
    
77. GRAYBURN PA, Packer M
    The Complex Phenotypic Expressions of Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2021;78:2422-2424.
    PubMed    
    
    
    
78. LAMPREA-MONTEALEGRE JA, Oyetunji S, Bagur R, Otto CM, et al
    Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9.
    J Am Coll Cardiol. 2021;78:2493-2504.
    PubMed     Abstract available
    
    
    
79. KOELL B, Orban M, Weimann J, Kassar M, et al
    Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.
    J Am Coll Cardiol. 2021;78:2408-2421.
    PubMed     Abstract available
    
    
    
80. LINDMAN BR, Sukul D, Dweck MR, Madhavan MV, et al
    Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:2354-2376.
    PubMed     Abstract available
    
    
    
81. CHIKWE J, O'Gara P, Gelijns A
    Reply: Reconsider the MitraClip for High-Risk Patients.
    J Am Coll Cardiol. 2021;78:e295.
    PubMed    
    
    
    
82. JIANG X, Liu J, Gu T
    Reconsider the MitraClip for High-Risk Patients.
    J Am Coll Cardiol. 2021;78:e293.
    PubMed    
    
    
    November 2021
83. VEMULAPALLI S, Thourani VH
    Aortic Valve Replacement and Patient-Centered Implementation: To Boldly Go Where No Device Has Gone Before.
    J Am Coll Cardiol. 2021;78:2173-2176.
    PubMed    
    
    
    
84. MORI M, Gupta A, Wang Y, Vahl T, et al
    Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States.
    J Am Coll Cardiol. 2021;78:2161-2172.
    PubMed     Abstract available
    
    
    
85. MARTINSSON A, Nielsen SJ, Milojevic M, Redfors B, et al
    Life Expectancy After Surgical Aortic Valve Replacement.
    J Am Coll Cardiol. 2021;78:2147-2157.
    PubMed     Abstract available
    
    
    
86. O'GARA PT, Sun YP, Patel SM
    Referral for Intervention in Severe Symptomatic Aortic Stenosis: Some Progress But Further Room for Improvement.
    J Am Coll Cardiol. 2021;78:2144-2146.
    PubMed    
    
    
    
87. EUGENE M, Duchnowski P, Prendergast B, Wendler O, et al
    Contemporary Management of Severe Symptomatic Aortic Stenosis.
    J Am Coll Cardiol. 2021;78:2131-2143.
    PubMed     Abstract available
    
    
    
88. GLASER N
    Can TAVR Match the Excellent Survival After SAVR in Younger, Low-Risk Patients?
    J Am Coll Cardiol. 2021;78:2158-2160.
    PubMed    
    
    
    
89. RODES-CABAU J, Regueiro A, Mack MJ
    Transcatheter Mitral Valve Replacement: A Need for Better Patient Selection.
    J Am Coll Cardiol. 2021;78:1860-1862.
    PubMed    
    
    
    
90. MULLER DWM, Sorajja P, Duncan A, Bethea B, et al
    2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.
    J Am Coll Cardiol. 2021;78:1847-1859.
    PubMed     Abstract available
    
    
    
91. SIMARD T, Jung RG, Hibbert B, Holmes DR Jr, et al
    Reply: Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e159.
    PubMed    
    
    
    
92. WANG X, Wang P, Pei H
    Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e157.
    PubMed    
    
    
    
93. ARBUSTINI E, Narula N
    Aortic Smooth Muscle Detraining in Continuous Flow LVAD: Out of Practice.
    J Am Coll Cardiol. 2021;78:1796-1799.
    PubMed    
    
    
    October 2021
94. MACK M, Carroll JD, Thourani V, Vemulapalli S, et al
    Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry.
    J Am Coll Cardiol. 2021 Oct 18. pii: S0735-1097(21)05852.
    PubMed     Abstract available
    
    
    September 2021
95. JEAN G, Pibarot P, Clavel MA
    Reply: Calcium Score to Specify Assessment of Low-Flow Aortic Stenosis Severity.
    J Am Coll Cardiol. 2021;78:e73.
    PubMed    
    
    
    
96. LAMM G, Auer J
    Calcium Score to Specify Assessment of Low-Flow Aortic Stenosis Severity.
    J Am Coll Cardiol. 2021;78:e71.
    PubMed    
    
    
    
97. BAUDHUIN LM
    Hypertrophic Cardiomyopathy in the General Population: Leveraging the UK Biobank Database and Machine Learning Phenotyping.
    J Am Coll Cardiol. 2021;78:1111-1113.
    PubMed    
    
    
    
98. DE MARVAO A, McGurk KA, Zheng SL, Thanaj M, et al
    Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:1097-1110.
    PubMed     Abstract available
    
    
    August 2021
99. GOMEZ JLZ, Gomez AG
    Aortic Valve Thrombosis: Be Prepared for the Unusual.
    J Am Coll Cardiol. 2021;78:825-826.
    PubMed    
    
    
    
100. ALAJAJI W, Hornick JM, Malek E, Klein AL, et al
     The Characteristics and Outcomes of Native Aortic Valve Thrombosis: A Systematic Review.
     J Am Coll Cardiol. 2021;78:811-824.
     PubMed     Abstract available
     
     
     
101. VALLE JA, Li Z, Kosinski AS, Nelson AJ, et al
     Dissemination of Transcatheter Aortic Valve Replacement in the United States.
     J Am Coll Cardiol. 2021;78:794-806.
     PubMed     Abstract available
     
     
     
102. HOLMES DR JR, Miller DC
     Rational Dispersion of TAVR: Failed Expectations and Unintended Consequences.
     J Am Coll Cardiol. 2021;78:807-810.
     PubMed    
     
     
     
103. O'SULLIVAN CJ
     Myocardial Damage and Severe Aortic Stenosis: Looking Beyond the Left Ventricular Ejection Fraction.
     J Am Coll Cardiol. 2021;78:559-561.
     PubMed    
     
     
     
104. KWAK S, Everett RJ, Treibel TA, Yang S, et al
     Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.
     J Am Coll Cardiol. 2021;78:545-558.
     PubMed     Abstract available
     
     
     July 2021
105. VERMA S, Latter DA, Bonow RO
     Failed Mitral TEER: Are There Lessons for Decision Making?
     J Am Coll Cardiol. 2021;78:10-13.
     PubMed    
     
     
     
106. CHIKWE J, O'Gara P, Fremes S, Sundt TM 3rd, et al
     Mitral Surgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic Surgeons Database Analysis.
     J Am Coll Cardiol. 2021;78:1-9.
     PubMed     Abstract available
     
     
     June 2021
107. ALPERI A, Granada JF, Bernier M, Dagenais F, et al
     Current Status and Future Prospects of Transcatheter Mitral Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:3058-3078.
     PubMed     Abstract available
     
     
     
108. KUZEMCZAK M, Lipiecki J, Siminiak T
     Transcatheter Mitral Valve Repair: When Is the Last Moment Before Crossing the Styx River?
     J Am Coll Cardiol. 2021;77:2982.
     PubMed    
     
     
     
109. MACK MJ, Stone GW
     Reply: Transcatheter Mitral Valve Repair: When Is the Last Moment Before Crossing the Styx River?
     J Am Coll Cardiol. 2021;77:2982-2983.
     PubMed    
     
     
     
110. ELMARIAH S, Patel NK
     Aortic Stenosis and LV Dysfunction: Not Everything in Moderation.
     J Am Coll Cardiol. 2021;77:2804-2806.
     PubMed    
     
     
     
111. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
     Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2021;77:2796-2803.
     PubMed     Abstract available
     
     
     
112. PFALLER B, Dave Javier A, Grewal J, Gabarin N, et al
     Risk Associated With Valvular Regurgitation During Pregnancy.
     J Am Coll Cardiol. 2021;77:2656-2664.
     PubMed     Abstract available
     
     
     
113. MCANULTY J
     Heart Valve Regurgitation in Pregnancy: Risks Related to the Company It Keeps.
     J Am Coll Cardiol. 2021;77:2665-2666.
     PubMed    
     
     
     May 2021
114. CHEN J, Lv M, Hu K, Ming Y, et al
     Isolated Severe Tricuspid Regurgitation: The Unsolved Challenge.
     J Am Coll Cardiol. 2021;77:2350-2351.
     PubMed    
     
     
     
115. CANNATA A, Cantoni S, Sciortino A, Bruschi G, et al
     Mechanical Hemolysis Complicating Transcatheter Interventions for Valvular Heart Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2323-2334.
     PubMed     Abstract available
     
     
     
116. NKOMO VT, DeSimone DC, Miranda WR
     Stroke Associated With Infective Endocarditis After Transcatheter Aortic Valve Replacement Is Devastating.
     J Am Coll Cardiol. 2021;77:2288-2290.
     PubMed    
     
     
     
117. DEL VAL D, Abdel-Wahab M, Mangner N, Durand E, et al
     Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2276-2287.
     PubMed     Abstract available
     
     
     
118. ALPERI A, Rodes-Cabau J, Simonato M, Tchetche D, et al
     Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry.
     J Am Coll Cardiol. 2021;77:2263-2273.
     PubMed     Abstract available
     
     
     
119. BARKER CM
     Permanent Pacemaker Implantation After TAVR for Degenerated Bioprosthetic Surgical Valves: We Could Do Better.
     J Am Coll Cardiol. 2021;77:2274-2275.
     PubMed    
     
     
     
120. FEISTRITZER HJ, Kurz T, Stachel G, Hartung P, et al
     Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2204-2215.
     PubMed     Abstract available
     
     
     
121. FAROUX L, Lhermusier T, Vincent F, Nombela-Franco L, et al
     ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2187-2199.
     PubMed     Abstract available
     
     
     
122. CZARNY MJ, Shah SJ, Whelton SP, Blaha MJ, et al
     Race/Ethnicity and Prevalence of Aortic Stenosis by Echocardiography in the Multi-Ethnic Study of Atherosclerosis.
     J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04964.
     PubMed    
     
     
     
123. KAPADIA SR, Krishnaswamy A
     Valve Choice in TAVR: A Complex Equation to Solve.
     J Am Coll Cardiol. 2021;77:2216-2218.
     PubMed    
     
     
     
124. GRUBERG L, Gandotra P
     STEMI Following TAVR: Unusual But Definitely Not Trivial.
     J Am Coll Cardiol. 2021;77:2200-2203.
     PubMed    
     
     
     
125. ROWIN EJ, Fifer MA
     Evaluating Histopathology to Improve Our Understanding of Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;77:2171-2173.
     PubMed    
     
     
     
126. CUI H, Schaff HV, Lentz Carvalho J, Nishimura RA, et al
     Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;77:2159-2170.
     PubMed     Abstract available
     
     
     April 2021
127. YAMMINE H, Briggs CS, Rolle QV, Ballast JK, et al
     Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair.
     J Am Coll Cardiol. 2021;77:2156-2157.
     PubMed    
     
     
     
128. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
     Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.
     J Am Coll Cardiol. 2021 Apr 15. pii: S0735-1097(21)00461.
     PubMed     Abstract available
     
     
     
129. MENTIAS A, Saad M, Desai MY, Krishnaswamy A, et al
     Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic Stenosis.
     J Am Coll Cardiol. 2021;77:1703-1713.
     PubMed     Abstract available
     
     
     March 2021
130. EL-HAMAMSY I, Warnes CA, Nishimura RA
     The Ross Procedure in Adults: The Ideal Aortic Valve Substitute?
     J Am Coll Cardiol. 2021;77:1423-1425.
     PubMed    
     
     
     
131. ABOUD A, Charitos EI, Fujita B, Stierle U, et al
     Long-Term Outcomes of Patients Undergoing the Ross Procedure.
     J Am Coll Cardiol. 2021;77:1412-1422.
     PubMed     Abstract available
     
     
     
132. MUNTANE-CAROL G, Philippon F, Nault I, Faroux L, et al
     Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:1344-1356.
     PubMed     Abstract available
     
     
     
133. ZYRIANOV A, Spirito P, Ferrazzi P, Pezzoli L, et al
     Reply: Hypertrophic Cardiomyopathy as Congenital Heart Disease.
     J Am Coll Cardiol. 2021;77:1378-1379.
     PubMed    
     
     
     
134. MURAKAMI T, Shiraishi M
     Hypertrophic Cardiomyopathy as Congenital Heart Disease.
     J Am Coll Cardiol. 2021;77:1377-1378.
     PubMed    
     
     
     
135. PRENDERGAST BD, Redwood SR, Patterson T
     TAVR Versus SAVR in Aortic Stenosis: Long Journey, New Roadmap.
     J Am Coll Cardiol. 2021;77:1162-1164.
     PubMed    
     
     
     
136. LEON MB, Mack MJ, Hahn RT, Thourani VH, et al
     Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.
     J Am Coll Cardiol. 2021;77:1149-1161.
     PubMed     Abstract available
     
     
     
137. MUSUMECI MB, Spirito P, Conte MR, Lillo R, et al
     Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;77:1262-1264.
     PubMed    
     
     
     
138. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
     3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:1029-1040.
     PubMed     Abstract available
     
     
     
139. DEPTA JP, Bhatt DL
     Crossover in COAPT: Does This Extend the Reach of TMVr for Treating Functional MR?
     J Am Coll Cardiol. 2021;77:1041-1043.
     PubMed    
     
     
     February 2021
140. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
     Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
     J Am Coll Cardiol. 2021;77:713-724.
     PubMed     Abstract available
     
     
     
141. TERNACLE J, Pibarot P, Hahn RT
     Reply: TAVR Versus SAVR or Valve Versus Valve?
     J Am Coll Cardiol. 2021;77:833-834.
     PubMed    
     
     
     
142. USEINI D
     TAVR Versus SAVR or Valve Versus Valve?
     J Am Coll Cardiol. 2021;77:832-833.
     PubMed    
     
     
     
143. MICK SL
     The Tricuspid Valve: No Longer Forgotten But Still Not Well Understood.
     J Am Coll Cardiol. 2021;77:725-727.
     PubMed    
     
     
     
144. PARK SJ, Lee S, Lee SA, Kim DH, et al
     Impact of Early Surgery and Staging Classification on Survival in Asymptomatic Very Severe Aortic Stenosis.
     J Am Coll Cardiol. 2021;77:506-508.
     PubMed    
     
     
     
145. ASGAR AW
     Transcatheter Tricuspid Valve Therapy: Zeroing in on the Target.
     J Am Coll Cardiol. 2021;77:357-359.
     PubMed    
     
     
     
146. KODALI S, Hahn RT, Eleid MF, Kipperman R, et al
     Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:345-356.
     PubMed     Abstract available
     
     
     January 2021
147. DONAL E, Leurent G, Iung B
     Are We Right to Believe in the Value of Transcatheter Treatment of Secondary Tricuspid Regurgitation?
     J Am Coll Cardiol. 2021;77:240-242.
     PubMed    
     
     
     
148. LURZ P, Stephan von Bardeleben R, Weber M, Sitges M, et al
     Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:229-239.
     PubMed     Abstract available
     
     
     
149. ALPERI A, Voisine P, Kalavrouziotis D, Dumont E, et al
     Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis Outside Randomized Trials.
     J Am Coll Cardiol. 2021;77:111-123.
     PubMed     Abstract available
     
     
     
150. VELAGAPUDI P, Bapat V, Kodali S
     When Excluded From Randomized Clinical Trials: To "OR" or "'TAVR"?
     J Am Coll Cardiol. 2021;77:124-127.
     PubMed    
     
     
     
151. LANDES U, Sathananthan J, Witberg G, De Backer O, et al
     Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses.
     J Am Coll Cardiol. 2021;77:1-14.
     PubMed     Abstract available
     
     
     
152. MORRAY BH, McElhinney DB
     Semilunar Valve Interventions for Congenital Heart Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:71-79.
     PubMed     Abstract available
     
     
     December 2020
153. EL-ESHMAWI A, Pandis D, Miller MA, Boateng P, et al
     Surgical Cryoablation of Papillary Muscle PVCs During Mitral Valve Surgery: Therapeutic Consideration for Malignant MVP.
     J Am Coll Cardiol. 2020;76:3061-3062.
     PubMed    
     
     
     
154. KLEIN AL, Ramchand J, Nagueh SF
     Aortic Stenosis and Diastolic Dysfunction: Partners in Crime.
     J Am Coll Cardiol. 2020;76:2952-2955.
     PubMed    
     
     
     
155. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
     Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
     J Am Coll Cardiol. 2020;76:2940-2951.
     PubMed     Abstract available
     
     
     
156. EGBE AC, Miranda WR, Dearani J, Kamath PS, et al
     Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.
     J Am Coll Cardiol. 2020;76:2968-2976.
     PubMed     Abstract available
     
     
     
157. OMMEN SR, Mital S, Burke MA, Day SM, et al
     2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020;76:e159-e240.
     PubMed    
     
     
     
158. OMMEN SR, Mital S, Burke MA, Day SM, et al
     2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020;76:3022-3055.
     PubMed     Abstract available
     
     
     
159. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
     2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020 Dec 17. pii: S0735-1097(20)37796.
     PubMed    
     
     
     
160. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
     2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020 Dec 10. pii: S0735-1097(20)37902.
     PubMed     Abstract available
     
     
     
161. PAPATHEODOROU E, Anastasakis A
     Arrhythmic Mitral Valve Prolapse: Implications for Family Screening and Sports Participation Eligibility.
     J Am Coll Cardiol. 2020;76:2691.
     PubMed    
     
     
     
162. ESSAYAGH B, Sabbag A, Benfari G, Enriquez-Sarano M, et al
     Reply: The Arrhythmic Mitral Valve Prolapse: The Questions and the Way Forward.
     J Am Coll Cardiol. 2020;76:2691-2693.
     PubMed    
     
     
     
163. MUTHUKUMAR L, Jan MF, Jahangir A, Tajik AJ, et al
     On Arrhythmic Mitral Valve Prolapse: The Devil Is in the Details.
     J Am Coll Cardiol. 2020;76:2690.
     PubMed    
     
     
     
164. HAN HC, Teh AW, Hare DL, Farouque O, et al
     The Clinical Demographics of Arrhythmic Mitral Valve Prolapse.
     J Am Coll Cardiol. 2020;76:2689-2690.
     PubMed    
     
     
     
165. ALQARAWI W, Cheung CC, Davies B, Krahn AD, et al
     Arrhythmic Mitral Valve Prolapse: Looking for a Needle in a Haystack.
     J Am Coll Cardiol. 2020;76:2688-2689.
     PubMed    
     
     
     
166. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
     Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:2595-2606.
     PubMed     Abstract available
     
     
     
167. RADERMECKER MA, Sprynger M, Hans G
     TAVR for Stenotic Bicuspid Aortic Valve: Feasible, Continuously Improving Results With Another Red Flag.
     J Am Coll Cardiol. 2020;76:2591-2594.
     PubMed    
     
     
     
168. FAN J, Fang X, Liu C, Zhu G, et al
     Brain Injury After Transcatheter Replacement of Bicuspid Versus Tricuspid Aortic Valves.
     J Am Coll Cardiol. 2020;76:2579-2590.
     PubMed     Abstract available
     
     
     
169. OPOTOWSKY AR, Dimopoulos K, Buber J
     Implications of Elevated Pulmonary Artery Pressure for Transcatheter Mitral Repair: Time for Comprehensive Hemodynamic Investigation.
     J Am Coll Cardiol. 2020;76:2607-2610.
     PubMed    
     
     
     
170. ALKHOULI M, Alqahtani F, Kawsara A, Pislaru S, et al
     National Trends in Mechanical Valve Replacement in Patients Aged 50 to 70 Years.
     J Am Coll Cardiol. 2020;76:2687-2688.
     PubMed    
     
     
     November 2020
171. MENTIAS A, Desai MY, Saad M, Rossen J, et al
     Transcatheter Aortic Valve Replacement in Kidney Transplant Patients.
     J Am Coll Cardiol. 2020;76:2571-2573.
     PubMed    
     
     
     
172. CARROLL JD, Mack MJ, Vemulapalli S, Herrmann HC, et al
     STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;76:2492-2516.
     PubMed     Abstract available
     
     
     
173. DANGAS GD, Adams DH
     Noncontrast Nephropathy After Percutaneous Mitral Valve Edge-to-Edge Repair.
     J Am Coll Cardiol. 2020;76:2474-2476.
     PubMed    
     
     
     
174. ARMIJO G, Estevez-Loureiro R, Carrasco-Chinchilla F, Arzamendi D, et al
     Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair.
     J Am Coll Cardiol. 2020;76:2463-2473.
     PubMed     Abstract available
     
     
     
175. LILLY SM, Deshmukh AJ, Epstein AE, Ricciardi MJ, et al
     2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement: A Report of the American College of Cardiology Solution Set Oversight Committee.
     J Am Coll Cardiol. 2020;76:2391-2411.
     PubMed     Abstract available
     
     
     
176. MORI M, Gan G, Bin Mahmood SU, Deng Y, et al
     Variations in Anticoagulation Practice Following Bioprosthetic Aortic and Mitral Valve Replacement and Repair.
     J Am Coll Cardiol. 2020;76:2412-2413.
     PubMed    
     
     
     
177. SHERRID MV, Adams DH
     The Mitral Valve in Hypertrophic Cardiomyopathy: Other Side of the Outflow Tract.
     J Am Coll Cardiol. 2020;76:2248-2251.
     PubMed    
     
     
     
178. FERRAZZI P, Spirito P, Binaco I, Zyrianov A, et al
     Congenital Muscular Mitral-Aortic Discontinuity Identified in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020;76:2238-2247.
     PubMed     Abstract available
     
     
     
179. ZAIDI AN, Adams DH
     Risk Assessment in Patients with Tricuspid Valve Regurgitation: MELD and Beyond.
     J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37755.
     PubMed    
     
     
     
180. PIBAROT P, Lancellotti P, Narula J
     Concomitant Cardiac Amyloidois in Severe Aortic Stenosis: The Trojan Horse?
     J Am Coll Cardiol. 2020 Nov 6. pii: S0735-1097(20)37752.
     PubMed    
     
     
     
181. NITSCHE C, Scully PR, Patel KP, Kammerlander A, et al
     Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.
     J Am Coll Cardiol. 2020 Nov 5. pii: S0735-1097(20)37735.
     PubMed     Abstract available
     
     
     
182. YANG LT, Daniels BK, Enriquez-Sarano M, Michelena HI, et al
     Reply: Beyond the Valve, Left Ventricle Remodeling May Be the Pivotal Factor for Survival in AR.
     J Am Coll Cardiol. 2020;76:2177-2179.
     PubMed    
     
     
     
183. JIANG X, Liu J, Gu T
     Beyond the Valve, Left Ventricle Remodeling May Be the Pivotal Factor for Survival in AR.
     J Am Coll Cardiol. 2020;76:2177.
     PubMed    
     
     
     October 2020
184. GUZZETTI E, Poulin A, Annabi MS, Kalavrouziotis D, et al
     Pre- and Post-Operative Stroke Volume Impact After Surgical Aortic Valve Replacement for Severe Aortic Stenosis.
     J Am Coll Cardiol. 2020;76:2036-2038.
     PubMed    
     
     
     
185. JAWITZ OK
     Surgical Aortic Valve Replacement for Failed TAVR Prostheses: One More Piece of the Puzzle.
     J Am Coll Cardiol. 2020;76:1860-1861.
     PubMed    
     
     
     
186. HIRJI SA, Percy ED, McGurk S, Malarczyk A, et al
     Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;76:1848-1859.
     PubMed     Abstract available
     
     
     
187. PIBAROT P, Ternacle J, Jaber WA, Salaun E, et al
     Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
     J Am Coll Cardiol. 2020;76:1830-1843.
     PubMed     Abstract available
     
     
     
188. VAN BELLE E, Delhaye C, Vincent F
     Structural Valve Deterioration at 5 Years of TAVR Versus SAVR: Half Full or Half Empty?
     J Am Coll Cardiol. 2020;76:1844-1847.
     PubMed    
     
     
     
189. ZHANG B, Salaun E, Cote N, Wu Y, et al
     Association of Bioprosthetic Aortic Valve Leaflet Calcification on Hemodynamic and Clinical Outcomes.
     J Am Coll Cardiol. 2020;76:1737-1748.
     PubMed     Abstract available
     
     
     
190. BORER JS
     Bioprosthesis Failure: Is Calcification the Only Problem?
     J Am Coll Cardiol. 2020;76:1749-1750.
     PubMed    
     
     
     September 2020
191. BURATTO E, Wallace FRO, Fricke TA, Brink J, et al
     Ross Procedures in Children With Previous Aortic Valve Surgery.
     J Am Coll Cardiol. 2020;76:1564-1573.
     PubMed     Abstract available
     
     
     
192. EL-HAMAMSY I, Stelzer P, Adams DH
     The Ross Procedure in Children Undergoing Reintervention: Another Victory for Nonthrombogenic Surgery.
     J Am Coll Cardiol. 2020;76:1574-1576.
     PubMed    
     
     
     
193. CUBEDDU RJ, Asher CR, Lowry AM, Blackstone EH, et al
     Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney Disease.
     J Am Coll Cardiol. 2020;76:1410-1421.
     PubMed     Abstract available
     
     
     
194. GALPER BZ, Goldsweig AM, Bhatt DL
     TAVR and the Kidney: Is This the Beginning of a Beautiful Friendship?
     J Am Coll Cardiol. 2020;76:1422-1424.
     PubMed    
     
     
     
195. SUN YP
     How Much Tricuspid Regurgitation?: To Clip or Not to Clip.
     J Am Coll Cardiol. 2020;76:1315-1317.
     PubMed    
     
     
     
196. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
     Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:1305-1314.
     PubMed     Abstract available
     
     
     
197. MYERSON SG
     Tricuspid Regurgitation: Understanding the "Problem Child".
     J Am Coll Cardiol. 2020;76:1302-1304.
     PubMed    
     
     
     
198. ZHAN Y, Debs D, Khan MA, Nguyen DT, et al
     Natural History of Functional Tricuspid Regurgitation Quantified by Cardiovascular Magnetic Resonance.
     J Am Coll Cardiol. 2020;76:1291-1301.
     PubMed     Abstract available
     
     
     
199. YOON SH, Kim WK, Dhoble A, Milhorini Pio S, et al
     Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;76:1018-1030.
     PubMed     Abstract available
     
     
     
200. GRAYBURN PA, Sannino A, Cohen DJ, Kar S, et al
     Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:1007-1014.
     PubMed     Abstract available
     
     
     
201. ANWARUDDIN S, Desai N
     Systematic Approach Toward Transcatheter Treatment of BAV Disease: One Size Does Not Fit All.
     J Am Coll Cardiol. 2020;76:1031-1033.
     PubMed    
     
     
     
202. HAHN RT
     Super-Responders and Nonresponders in the COAPT Trial: Not as Simple as Clip or No Clip.
     J Am Coll Cardiol. 2020;76:1015-1017.
     PubMed    
     
     
     August 2020
203. KAUL S
     Raising the Evidentiary Bar for Guideline Recommendations for TAVR: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:985-991.
     PubMed     Abstract available
     
     
     
204. SANNINO A, Sudhakaran S, Milligan G, Chowdhury A, et al
     Effectiveness of Medical Therapy for Functional Mitral Regurgitation in Heart Failure With Reduced Ejection Fraction.
     J Am Coll Cardiol. 2020;76:883-884.
     PubMed    
     
     
     
205. LAURA B, Filippo C, Enrica B, Gino G, et al
     Letter to the Editor: What Happens to the Aortic Root Morphology and Flow When We Replace the Aortic Valve?
     J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36306.
     PubMed    
     
     
     
206. ROWIN EJ, Maron BJ, Maron MS
     The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36310.
     PubMed    
     
     
     
207. DALZELL JR, Connolly EC, Cannon JA
     The LVAD in the management of advanced heart failure due to hypertrophic cardiomyopathy.
     J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36312.
     PubMed    
     
     
     
208. GARBI M, Garweg C
     Arrhythmia in Mitral Valve Prolapse: All Roads Lead to Rome.
     J Am Coll Cardiol. 2020;76:650-652.
     PubMed    
     
     
     
209. ESSAYAGH B, Sabbag A, Antoine C, Benfari G, et al
     Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.
     J Am Coll Cardiol. 2020;76:637-649.
     PubMed     Abstract available
     
     
     
210. LOPEZ-CANDALES A, Vallurupalli S
     Refining Prognostication of Severe Aortic Stenosis: The Q Factor.
     J Am Coll Cardiol. 2020;76:634.
     PubMed    
     
     
     
211. NAMASIVAYAM M, Churchill TW, Hung J
     Reply: Refining Prognostication of Severe Aortic Stenosis: The Q Factor.
     J Am Coll Cardiol. 2020;76:634-635.
     PubMed    
     
     
     
212. BORGER MA, Raschpichler M, Makkar R
     Repeat Aortic Valve Surgery or Transcatheter Valve-in-Valve Therapy: We Need a Randomized Trial.
     J Am Coll Cardiol. 2020;76:500-502.
     PubMed    
     
     
     
213. DEHARO P, Bisson A, Herbert J, Lacour T, et al
     Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement.
     J Am Coll Cardiol. 2020;76:489-499.
     PubMed     Abstract available
     
     
     
214. SEMSARIAN C, Semsarian CR
     Variable Penetrance in Hypertrophic Cardiomyopathy: In Search of the Holy Grail.
     J Am Coll Cardiol. 2020;76:560-562.
     PubMed    
     
     
     
215. LORENZINI M, Norrish G, Field E, Ochoa JP, et al
     Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
     J Am Coll Cardiol. 2020;76:550-559.
     PubMed     Abstract available
     
     
     July 2020
216. KOCHILAS L
     Atrioventricular Valve Regurgitation in the Single Ventricle: Back to Hippocrates.
     J Am Coll Cardiol. 2020;76:432-434.
     PubMed    
     
     
     
217. MOON J, Shen L, Likosky DS, Sood V, et al
     Relationship of Ventricular Morphology and Atrioventricular Valve Function to Long-Term Outcomes Following Fontan Procedures.
     J Am Coll Cardiol. 2020;76:419-431.
     PubMed     Abstract available
     
     
     
218. TRIBOUILLOY C, Bohbot Y, Unger P
     Mitral Regurgitation in Patients With Severe Aortic Regurgitation: When Misery Loves Company.
     J Am Coll Cardiol. 2020;76:247-250.
     PubMed    
     
     
     
219. YANG LT, Enriquez-Sarano M, Scott CG, Padang R, et al
     Concomitant Mitral Regurgitation in Patients With Chronic Aortic Regurgitation.
     J Am Coll Cardiol. 2020;76:233-246.
     PubMed     Abstract available
     
     
     June 2020
220. SENGUPTA SP, Mohan JC
     Calcific Mitral Stenosis: Echoes of Aging.
     J Am Coll Cardiol. 2020;75:3058-3060.
     PubMed    
     
     
     
221. KATO N, Padang R, Scott CG, Guerrero M, et al
     The Natural History of Severe Calcific Mitral Stenosis.
     J Am Coll Cardiol. 2020;75:3048-3057.
     PubMed     Abstract available
     
     
     
222. STORTECKY S, Heg D, Tueller D, Pilgrim T, et al
     Infective Endocarditis After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;75:3020-3030.
     PubMed     Abstract available
     
     
     
223. GIUSTINO G, Genereux P
     Subclinical Thrombosis of Bioprosthetic Aortic Valves.
     J Am Coll Cardiol. 2020;75:3016-3019.
     PubMed    
     
     
     
224. BRINKLEY DM, Wells QS, Stevenson LW
     Avoiding Burnout From Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020;75:3044-3047.
     PubMed    
     
     
     
225. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
     Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
     J Am Coll Cardiol. 2020;75:3033-3043.
     PubMed     Abstract available
     
     
     
226. MAKKAR RR, Blanke P, Leipsic J, Thourani V, et al
     Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.
     J Am Coll Cardiol. 2020;75:3003-3015.
     PubMed     Abstract available
     
     
     
227. WILCOX JE, McNally EM
     Lessons From MAVERICK-HCM: The Need for Less Speed.
     J Am Coll Cardiol. 2020;75:2661-2663.
     PubMed    
     
     
     
228. HO CY, Mealiffe ME, Bach RG, Bhattacharya M, et al
     Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020;75:2649-2660.
     PubMed     Abstract available
     
     
     May 2020
229. MENTIAS A, Sarrazin MV, Desai MY, Saad M, et al
     Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Stenosis.
     J Am Coll Cardiol. 2020;75:2518-2519.
     PubMed    
     
     
     
230. VANNAN MA, Tridetti J, Lancellotti P
     Intervention In Severe Aortic Stenosis: It May Be Time When the Left Ventricle Says So.
     J Am Coll Cardiol. 2020;75:2459-2462.
     PubMed    
     
     
     
231. CHAU KH, Douglas PS, Pibarot P, Hahn RT, et al
     Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
     J Am Coll Cardiol. 2020;75:2446-2458.
     PubMed     Abstract available
     
     
     
232. KEFER J
     Hypoattenuated Leaflet Thickening in Transcatheter and Surgical Aortic Valves.
     J Am Coll Cardiol. 2020;75:2443-2445.
     PubMed    
     
     
     
233. LEE SA, Park SJ, Lee S, Kim DH, et al
     Long-Term Survival of Asymptomatic Patients With Very Severe Aortic Stenosis: Early Surgery Versus Conventional Treatment.
     J Am Coll Cardiol. 2020;75:2379-2380.
     PubMed    
     
     
     
234. YANG LT, Scott CG, Enriquez-Sarano M, Michelena HI, et al
     Reply: Mortality-Association of Diastolic Blood Pressure and Heart Rate in Aortic Regurgitation: A Matter of Fact.
     J Am Coll Cardiol. 2020;75:2276-2278.
     PubMed    
     
     
     
235. ALOIA E
     Resting Heart Rate and Diastolic Blood Pressure in AR: Still a Matter of Debate.
     J Am Coll Cardiol. 2020;75:2276.
     PubMed    
     
     
     
236. JIANG X, Zhang Y, Gu T
     Cardiac Output and Blood Supply of Cardiomyocytes May Be Determinants of Clinical Outcomes in AR.
     J Am Coll Cardiol. 2020;75:2275-2276.
     PubMed    
     
     
     
237. MEINERTZ T, Munzel T
     Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
     J Am Coll Cardiol. 2020;75:2107-2109.
     PubMed    
     
     
     April 2020
238. ASCH FM, Stone GW, Weissman NJ
     Reply: Disproportionate Secondary Mitral Regurgitation: An Exciting Hypothesis Still in Need of Actual Data.
     J Am Coll Cardiol. 2020;75:2096-2097.
     PubMed    
     
     
     
239. ENNEZAT PV, Malergue MC, Le Jemtel TH
     Even Disproportionate Secondary COAPT Mitral Regurgitation Should Obey Antoine Lavoisier's Law.
     J Am Coll Cardiol. 2020;75:2095-2096.
     PubMed    
     
     
     
240. FENG J, Bao X, Li T, Zhao Y, et al
     Endovascular Reconstruction From Aortic Valve to Aortic Arch Using 1-Piece Valved Fenestrated Bifurcated Endografting.
     J Am Coll Cardiol. 2020;75:2090-2092.
     PubMed    
     
     
     
241. O'GARA PT, Shah PB, Sun YP
     Paradoxical Low Flow Aortic Stenosis: More Differences Between Men and Women.
     J Am Coll Cardiol. 2020;75:1910-1912.
     PubMed    
     
     
     
242. GUZZETTI E, Poulin A, Annabi MS, Zhang B, et al
     Transvalvular Flow, Sex, and Survival After Valve Replacement Surgery in Patients With Severe Aortic Stenosis.
     J Am Coll Cardiol. 2020;75:1897-1909.
     PubMed     Abstract available
     
     
     
243. LANDES U, Webb JG, De Backer O, Sondergaard L, et al
     Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction.
     J Am Coll Cardiol. 2020;75:1882-1893.
     PubMed     Abstract available
     
     
     
244. MEHMOOD M
     Echocardiographic Outcomes in the COAPT Trial: Asking the "Right" Question.
     J Am Coll Cardiol. 2020;75:2095.
     PubMed    
     
     
     
245. THOURANI VH, Edelman JJ, Meduri CU
     TAVR in TAVR: The Future Is Now.
     J Am Coll Cardiol. 2020;75:1894-1896.
     PubMed    
     
     
     
246. SENIOR R, Khattar RS
     Assessment of Aortic Stenosis: Time to Go With the Flow.
     J Am Coll Cardiol. 2020;75:1770-1771.
     PubMed    
     
     
     
247. NAMASIVAYAM M, He W, Churchill TW, Capoulade R, et al
     Transvalvular Flow Rate Determines Prognostic Value of Aortic Valve Area in Aortic Stenosis.
     J Am Coll Cardiol. 2020;75:1758-1769.
     PubMed     Abstract available
     
     
     
248. TASTET L, Shen M, Capoulade R, Arsenault M, et al
     Bone Mineral Density and Progression Rate of Calcific Aortic Valve Stenosis.
     J Am Coll Cardiol. 2020;75:1725-1726.
     PubMed    
     
     
     
249. ZHANG B, Xu H, Zhang H, Liu Q, et al
     Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
     J Am Coll Cardiol. 2020;75:1659-1672.
     PubMed     Abstract available
     
     
     
250. BERGLER-KLEIN J
     NT-proBNP as a Cornerstone for Prognosis in Valve Disease: All We Need Is Blood.
     J Am Coll Cardiol. 2020;75:1673-1675.
     PubMed    
     
     
     March 2020
251. VLASTRA W, van Nieuwkerk AC, Santos RB, Chandrasekhar J, et al
     Reply: Sex Differences With Transcatheter Aortic Valve Replacement: Not So Surprising Results.
     J Am Coll Cardiol. 2020;75:1499-1500.
     PubMed    
     
     
     
252. ILYAS I, Doshi R
     Sex Differences With Transcatheter Aortic Valve Replacement: Not So Surprising Results.
     J Am Coll Cardiol. 2020;75:1498-1499.
     PubMed    
     
     
     
253. KHAN JM, Rogers T, Greenbaum AB, Babaliaros VC, et al
     Transcatheter Electrosurgery: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2020;75:1455-1470.
     PubMed     Abstract available
     
     
     
254. BLANKE P, Leipsic JA, Popma JJ, Yakubov SJ, et al
     Leaflet Thickening or Immobility Following Aortic Valve Replacement: Results from the Evolut Low Risk Sub-study.
     J Am Coll Cardiol. 2020 Mar 18. pii: S0735-1097(20)34583.
     PubMed     Abstract available
     
     
     
255. DIMITROW PP, Rajtar-Salwa R
     Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study.
     J Am Coll Cardiol. 2020;75:1242.
     PubMed    
     
     
     
256. KRAMER CM, Neubauer S
     Reply: Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study.
     J Am Coll Cardiol. 2020;75:1242-1243.
     PubMed    
     
     
     
257. COYLEWRIGHT M, Forrest JK, McCabe JM, Nazif TM, et al
     TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making.
     J Am Coll Cardiol. 2020;75:1208-1211.
     PubMed    
     
     
     
258. DESHAIES C, Trottier H, Khairy P, Al-Aklabi M, et al
     Tricuspid Intervention Following Pulmonary Valve Replacement in Adults With Congenital Heart Disease.
     J Am Coll Cardiol. 2020;75:1033-1043.
     PubMed     Abstract available
     
     
     
259. ARNOLD SV, Stone GW, Mack MJ, Chhatriwalla AK, et al
     Health Status Changes and Outcomes in Patients with Heart Failure and Mitral Regurgitation: From COAPT.
     J Am Coll Cardiol. 2020 Mar 4. pii: S0735-1097(20)34413.
     PubMed     Abstract available
     
     
     February 2020
260. STRANGE G, Stewart S, Playford D
     Reply: Poor Outcomes in Patients With Moderate Aortic Stenosis: Let's Review the Data.
     J Am Coll Cardiol. 2020;75:838-839.
     PubMed    
     
     
     
261. KAMPAKTSIS PN, Avgerinos DV, Vavuranakis M
     Poor Outcomes in Patients With Moderate Aortic Stenosis: Let's Review the Data.
     J Am Coll Cardiol. 2020;75:837.
     PubMed    
     
     
     
262. KLEIN AL, Wang TKM, Popovic ZB
     Put a Strain on Secondary Mitral Regurgitation: Functional or Dysfunctional?
     J Am Coll Cardiol. 2020;75:759-762.
     PubMed    
     
     
     
263. NAMAZI F, van der Bijl P, Hirasawa K, Kamperidis V, et al
     Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Secondary Mitral Regurgitation.
     J Am Coll Cardiol. 2020;75:750-758.
     PubMed     Abstract available
     
     
     
264. ENGEL TR
     Diagnosis of Hypertrophic Cardiomyopathy: Who Is in Charge Here-The Physician or the Computer?
     J Am Coll Cardiol. 2020;75:734-735.
     PubMed    
     
     
     
265. KO WY, Siontis KC, Attia ZI, Carter RE, et al
     Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram.
     J Am Coll Cardiol. 2020;75:722-733.
     PubMed     Abstract available
     
     
     
266. BONOW RO, O'Gara PT, Adams DH, Badhwar V, et al
     2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation.
     J Am Coll Cardiol. 2020 Feb 10. pii: S0735-1097(20)30427.
     PubMed     Abstract available
     
     
     
267. POPOVIC ZB
     Mitral Valve Histology: Barren Ground or Tropical Rainforest?
     J Am Coll Cardiol. 2020;75:406-408.
     PubMed    
     
     
     
268. MARSIT O, Clavel MA, Cote-Laroche C, Hadjadj S, et al
     Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction.
     J Am Coll Cardiol. 2020;75:395-405.
     PubMed     Abstract available
     
     
     
269. LOVE BA
     Adverse Events Due to Transcatheter Pulmonary Valve Replacement: We Are Being too Hard on Ourselves.
     J Am Coll Cardiol. 2020;75:377-379.
     PubMed    
     
     
     
270. GOLDSTEIN BH, Bergersen L, Armstrong AK, Boe BA, et al
     Adverse Events, Radiation Exposure, and Reinterventions Following Transcatheter Pulmonary Valve Replacement.
     J Am Coll Cardiol. 2020;75:363-376.
     PubMed     Abstract available
     
     
     January 2020
271. MILLER CA, Lewis GA, Ray SG
     Beyond Valvular Heart Disease.
     J Am Coll Cardiol. 2020;75:317-319.
     PubMed    
     
     
     
272. EVERETT RJ, Treibel TA, Fukui M, Lee H, et al
     Extracellular Myocardial Volume in Patients With Aortic Stenosis.
     J Am Coll Cardiol. 2020;75:304-316.
     PubMed     Abstract available
     
     
     
273. KOLTE D, Elmariah S
     Reply: Certainty in Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
     J Am Coll Cardiol. 2020;75:243.
     PubMed    
     
     
     
274. LIANG F, Song B, Wang Q, Wang X, et al
     Certainty in Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
     J Am Coll Cardiol. 2020;75:242-243.
     PubMed    
     
     
     
275. OURY C, Donis N, Marechal P
     Can Body Fat Cause Aortic Stenosis?: Lessons From Genetics.
     J Am Coll Cardiol. 2020;75:177-179.
     PubMed    
     
     
     
276. KALTOFT M, Langsted A, Nordestgaard BG
     Obesity as a Causal Risk Factor for Aortic Valve Stenosis.
     J Am Coll Cardiol. 2020;75:163-176.
     PubMed     Abstract available
     
     
     
277. CHAMBERS J
     Aortic Regurgitation: The Value of Clinical Signs.
     J Am Coll Cardiol. 2020;75:40-41.
     PubMed    
     
     
     
278. YANG LT, Pellikka PA, Enriquez-Sarano M, Scott CG, et al
     Diastolic Blood Pressure and Heart Rate Are Independently Associated With Mortality in Chronic Aortic Regurgitation.
     J Am Coll Cardiol. 2020;75:29-39.
     PubMed     Abstract available
     
     
     
279. TANG G, Zhou X
     Some Questions on the Study of Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;75:125.
     PubMed    
     
     
     
280. RODRIGUEZ-GABELLA T, Catala P, Carrasco-Moraleja M, San Roman Calvar JA, et al
     Reply: Some Questions on the Study of Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;75:125-126.
     PubMed    
     
     
     December 2019
281. MAMANE S, Mullie L, Lok Ok Choo W, Piazza N, et al
     Sarcopenia in Older Adults Undergoing Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2019;74:3178-3180.
     PubMed    
     
     
     
282. TANG GHL
     Echocardiographic Understanding of Secondary Mitral Regurgitation in Transcatheter Mitral Valve Repair: More to Learn.
     J Am Coll Cardiol. 2019;74:2980-2981.
     PubMed    
     
     
     
283. BONOW RO, O'Gara PT, Adams DH, Badhwar V, et al
     2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the American Association for Thoracic Surgery, the American Co
     J Am Coll Cardiol. 2019 Dec 9. pii: S0735-1097(19)38566.
     PubMed    
     
     
     
284. AXTELL AL, Wasfy JH
     Reply: Isolated Severe Tricuspid Regurgitation: Opportunities for Future Research.
     J Am Coll Cardiol. 2019;74:2830-2831.
     PubMed    
     
     
     
285. MIURA M, Taramasso M, Gavazzoni M, Zuber M, et al
     What Is the Best Option in Patients With Isolated Severe Tricuspid Regurgitation?
     J Am Coll Cardiol. 2019;74:2829.
     PubMed    
     
     
     
286. DELGADO V, Vollema EM, Tastet L, Pibarot P, et al
     Reply: Staging Cardiac Damage in Aortic Stenosis.
     J Am Coll Cardiol. 2019;74:2826.
     PubMed    
     
     
     
287. FUKUI M, Gleason TG, Cavalcante JL
     Staging Classification for Aortic Stenosis.
     J Am Coll Cardiol. 2019;74:2825-2826.
     PubMed    
     
     
     
288. ALKHALIL M
     Staging Cardiac Damage in Aortic Stenosis.
     J Am Coll Cardiol. 2019;74:2824-2825.
     PubMed    
     
     
     
289. SALEMI A, Gaudino M, Bakaeen F, Mao J, et al
     Operator Volume to Outcome Relationship in Mitral and Aortic Valve Replacement.
     J Am Coll Cardiol. 2019;74:2821-2822.
     PubMed    
     
     
     
290. KAPADIA SR, Krishnaswamy A
     Bleeding and Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2019;74:2768-2770.
     PubMed    
     
     
     
291. BEURTHERET S, Karam N, Resseguier N, Houel R, et al
     Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2019;74:2728-2739.
     PubMed     Abstract available
     
     
     November 2019
292. MATSUSHITA K, Marchandot B, Kibler M, Trimaille A, et al
     P2Y12 Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2019;74:2707-2708.
     PubMed    
     
     
     
293. TERNACLE J, Krapf L, Mohty D, Magne J, et al
     Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2019;74:2638-2651.
     PubMed     Abstract available
     
     
     
294. MOSKOWITZ G, Hong KN, Giustino G, Gillinov AM, et al
     Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve Surgery.
     J Am Coll Cardiol. 2019;74:2607-2620.
     PubMed     Abstract available
     
     
     
295. VANOVERSCHELDE JL, Vancraeynest D
     Progression of Aortic Regurgitation: The Missing Link Between Disease Severity and Clinical Complications.
     J Am Coll Cardiol. 2019;74:2493-2495.
     PubMed    
     
     
     
296. YANG LT, Enriquez-Sarano M, Michelena HI, Nkomo VT, et al
     Predictors of Progression in Patients With Stage B Aortic Regurgitation.
     J Am Coll Cardiol. 2019;74:2480-2492.
     PubMed     Abstract available
     
     
     
297. BATCHELOR W, Anwaruddin S, Ross L, Alli O, et al
     Aortic Valve Stenosis Treatment Disparities in the Underserved: JACC Council Perspectives.
     J Am Coll Cardiol. 2019;74:2313-2321.
     PubMed     Abstract available
     
     
     October 2019
298. SZERLIP M, Zajarias A
     Reply: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease: Aligning Treatment Goals With Expectations.
     J Am Coll Cardiol. 2019;74:2220-2221.
     PubMed    
     
     
     
299. PALAMUTHUSINGAM D, Nath K, Reyaldeen R
     Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease: Aligning Treatment Goals With Expectations.
     J Am Coll Cardiol. 2019;74:2219-2220.
     PubMed    
     
     
     
300. MANGIERI A, Montalto C, Poletti E, Sticchi A, et al
     Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2019;74:2088-2101.
     PubMed     Abstract available
     
     
     
301. VANNAN MA, Pibarot P, Lancellotti P
     Aortic Stenosis: The Emperor's New Clothes.
     J Am Coll Cardiol. 2019;74:1864-1867.
     PubMed    
     
     
     
302. TAN TC, Nunes MCP
     Assessment of Secondary Mitral Regurgitation: Why an Integrated Approach Really Matters.
     J Am Coll Cardiol. 2019;74:1845.
     PubMed    
     
     
     
303. BARTKO PE, Pavo N, Spinka G, Hulsmann M, et al
     Reply: Assessment of Secondary Mitral Regurgitation: Why an Integrated Approach Really Matters.
     J Am Coll Cardiol. 2019;74:1845-1847.
     PubMed    
     
     
     September 2019
304. ALKHOULI M, Lopez JJ, Mathew V
     Transcatheter Therapy for Severe Tricuspid Regurgitation: Learning to Understand the Forgotten Valve.
     J Am Coll Cardiol. 2019 Sep 24. pii: S0735-1097(19)37740.
     PubMed    
     
     
     
305. TARAMASSO M, Benfari G, van der Bijl P, Alessandrini H, et al
     Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation.
     J Am Coll Cardiol. 2019 Sep 24. pii: S0735-1097(19)37739.
     PubMed     Abstract available
     
     
     
306. VLASTRA W, Chandrasekhar J, Del Blanco BG, Tchetche D, et al
     Gender Differences in Transfemoral Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2019 Sep 20. pii: S0735-1097(19)37669.
     PubMed     Abstract available
     
     
     
307. ASCH FM, Grayburn PA, Siegel RJ, Kar S, et al
     Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial.
     J Am Coll Cardiol. 2019 Sep 19. pii: S0735-1097(19)37678.
     PubMed     Abstract available
     
     
     
308. CHHATRIWALLA AK, Vemulapalli S, Szerlip M, Kodali S, et al
     Operator Experience and Procedural Results of Transcatheter Mitral Valve Repair in the United States.
     J Am Coll Cardiol. 2019 Sep 19. pii: S0735-1097(19)37668.
     PubMed     Abstract available
     
     
     
309. BARON SJ, Magnuson EA, Lu M, Wang K, et al
     Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis.
     J Am Coll Cardiol. 2019 Sep 18. pii: S0735-1097(19)37633.
     PubMed     Abstract available
     
     
     July 2019
310. GIANCATERINO S, Hsu JC
     Valvular Atrial Fibrillation: A Confusing and Obsolete Definition.
     J Am Coll Cardiol. 2019;73:3360-3361.
     PubMed    
     
     
     June 2019
311. PRIETO-AREVALO R, Munoz P, Cuerpo G, Mari-Hualde A, et al
     Pulmonary Infective Endocarditis.
     J Am Coll Cardiol. 2019;73:2782-2784.
     PubMed    
     
     
     May 2019
312. MCKENNA WJ, Moon JC, Sulaiman A
     Understanding the Myocardial Architecture of Hypertrophic Cardiomyopathy for Clinical Care.
     J Am Coll Cardiol. 2019;73:2503-2505.
     PubMed    
     
     
     
313. ARIGA R, Tunnicliffe EM, Manohar SG, Mahmod M, et al
     Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
     J Am Coll Cardiol. 2019;73:2493-2502.
     PubMed     Abstract available
     
     
     
314. ANDELFINGER G, Marquis C, Raboisson MJ, Theoret Y, et al
     Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition.
     J Am Coll Cardiol. 2019;73:2237-2239.
     PubMed    
     
     
     April 2019
315. MARON BJ, Maron MS, Maron BA, Loscalzo J, et al
     Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2019;73:1978-1986.
     PubMed     Abstract available
     
     
     
316. SMYRNIAS I, Gray SP, Okonko DO, Sawyer G, et al
     Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload.
     J Am Coll Cardiol. 2019;73:1795-1806.
     PubMed     Abstract available
     
     
     
317. BATZNER A, Seggewiss H
     Reply: Reliability of Echo-Guided Septal Ablation in Hypertrophic Cardiomyopathy: First Choice Also in Young Patients?
     J Am Coll Cardiol. 2019;73:1739-1740.
     PubMed    
     
     
     
318. JURADO-ROMAN A, Piqueras Flores J
     Reliability of Echo-Guided Septal Ablation in Hypertrophic Cardiomyopathy: First Choice Also in Young Patients?
     J Am Coll Cardiol. 2019;73:1738-1739.
     PubMed    
     
     
     March 2019
319. OCHOA JP, Elliott PM, Gimeno JR, Monserrat L, et al
     Reply: Revisiting Genome Sequencing Data in Light of Novel Disease Gene Associations.
     J Am Coll Cardiol. 2019;73:1366-1367.
     PubMed    
     
     
     
320. SEMSARIAN C, Ingles J, Bagnall RD
     Revisiting Genome Sequencing Data in Light of Novel Disease Gene Associations.
     J Am Coll Cardiol. 2019;73:1365-1366.
     PubMed    
     
     
     
321. SORAJJA P, Moat N, Badhwar V, Walters D, et al
     Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients.
     J Am Coll Cardiol. 2019;73:1250-1260.
     PubMed     Abstract available
     
     
     
322. IUNG B
     Hospital Resource Use After TAVR: Clinical and Economic Lessons From Merging Large Databases.
     J Am Coll Cardiol. 2019;73:1147-1148.
     PubMed    
     
     
     
323. FAYAD ZA, Calcagno C
     Sodium Fluoride PET and Aortic Bioprosthetic Valve Degeneration: Implications for Patient Diagnosis, Management, and Treatment.
     J Am Coll Cardiol. 2019;73:1120-1122.
     PubMed    
     
     
     
324. VAN BELLE E, Vincent F, Rauch A, Casari C, et al
     von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2019;73:1078-1088.
     PubMed     Abstract available
     
     
     February 2019
325. CETTA F, Driscoll DJ
     Bad Atrioventricular Valve, Bad Fontan: Stop Creating Bad Fontans.
     J Am Coll Cardiol. 2019;73:823-825.
     PubMed    
     
     
     
326. KING G, Ayer J, Celermajer D, Zentner D, et al
     Atrioventricular Valve Failure in Fontan Palliation.
     J Am Coll Cardiol. 2019;73:810-822.
     PubMed     Abstract available
     
     
     
327. ANWARUDDIN S, Saybolt MD
     Improving Quality and Outcomes in TAVR: Turning Up the Volume?
     J Am Coll Cardiol. 2019;73:441-443.
     PubMed    
     
     
     January 2019
328. OVERTCHOUK P, Guedeney P, Rouanet S, Verhoye JP, et al
     Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.
     J Am Coll Cardiol. 2019;73:13-21.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: